_:vb50941446	<http://www.w3.org/2002/07/owl#annotatedSource>	<http://purl.obolibrary.org/obo/DOID_0080687> .
_:vb50941446	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/2002/07/owl#Axiom> .
_:vb50941446	<http://www.w3.org/2002/07/owl#annotatedProperty>	<http://purl.obolibrary.org/obo/IAO_0000115> .
_:vb50941446	<http://www.w3.org/2007/05/powder-s#describedby>	<https://demo.openlinksw.com/about/id/entity/http/purl.obolibrary.org/obo/doid.owl> .
_:vb50941446	<http://www.geneontology.org/formats/oboInOwl#hasDbXref>	"url:https://pubmed.ncbi.nlm.nih.gov/18952429/"^^<http://www.w3.org/2001/XMLSchema#string> .
_:vb50941446	<http://www.w3.org/2002/07/owl#annotatedTarget>	"A myopathy that is characterized by by the presence of intracytoplasmic inclusion bodies strongly stained by menadione-linked alpha-glycerophosphate dehydrogenase in the absence of substrate, alpha-glycerophosphate, with late childhood or adult onset, and that has_material_basis_in mutation in the FHL1 gene on chromosome Xq26."^^<http://www.w3.org/2001/XMLSchema#string> .